Omega Tots Long Term Follow-up

• Status: Enrolling by invitation
• Trial end date: 2024-12-31
• Target enrollment: 0
• Participant gender: All

Summary

This is a continuation study to the Omega Tots trial (NCT01576783). The purpose of this study is to follow-up with participants of the original study to determine the long-term effect a daily fatty acid dietary supplement taken during toddlerhood might have on children born preterm now that they are 8.5-10.5 years old.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sarah Keim
• Collaborator: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Criteria

Inclusion Criteria:

• Previous participation in Omega Tots (NCT01576783).

• Current age of 8 years, 180 days to 10 years, 180 days.

Exclusion Criteria:

• Child in custody of children's services for their window of eligibility